| Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells N Seddiki, B Santner-Nanan, J Martinson, J Zaunders, S Sasson, ... The Journal of experimental medicine 203 (7), 1693-1700, 2006 | 2035 | 2006 |
| Upregulation of CTLA-4 by HIV-specific CD4+ T cells correlates with disease progression and defines a reversible immune dysfunction DE Kaufmann, DG Kavanagh, F Pereyra, JJ Zaunders, EW Mackey, ... Nature immunology 8 (11), 1246-1254, 2007 | 702 | 2007 |
| Characterization of CD4+ CTLs ex vivo V Appay, JJ Zaunders, L Papagno, J Sutton, A Jaramillo, A Waters, ... The Journal of Immunology 168 (11), 5954-5958, 2002 | 692 | 2002 |
| Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection C Phetsouphanh, DR Darley, DB Wilson, A Howe, C Munier, SK Patel, ... Nature immunology 23 (2), 210-216, 2022 | 654 | 2022 |
| Clustered mutations in HIV-1 gag are consistently required for escape from HLA-B27–restricted cytotoxic T lymphocyte responses AD Kelleher, C Long, EC Holmes, RL Allen, J Wilson, C Conlon, ... The Journal of experimental medicine 193 (3), 375-386, 2001 | 588 | 2001 |
| Viral suppression and HIV transmission in serodiscordant male couples: an international, prospective, observational, cohort study BR Bavinton, AN Pinto, N Phanuphak, B Grinsztejn, GP Prestage, ... The lancet HIV 5 (8), e438-e447, 2018 | 510 | 2018 |
| Early highly active antiretroviral therapy for acute HIV-1 infection preserves immune function of CD8+ and CD4+ T lymphocytes A Oxenius, DA Price, PJ Easterbrook, CA O'Callaghan, AD Kelleher, ... Proceedings of the National Academy of Sciences 97 (7), 3382-3387, 2000 | 493 | 2000 |
| Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2 … P Cahn, JS Madero, JR Arribas, A Antinori, R Ortiz, AE Clarke, CC Hung, ... The Lancet 393 (10167), 143-155, 2019 | 397 | 2019 |
| Alterations in the immune response of human immunodeficiency virus (HIV)-infected subjects treated with an HIV-specific protease inhibitor, ritonavir AD Kelleher, A Carr, J Zaunders, DA Cooper Journal of Infectious Diseases 173 (2), 321-329, 1996 | 396 | 1996 |
| Escape from the dominant HLA-B27-restricted cytotoxic T-lymphocyte response in Gag is associated with a dramatic reduction in human immunodeficiency virus type 1 replication A Schneidewind, MA Brockman, R Yang, RI Adam, B Li, S Le Gall, ... Journal of virology 81 (22), 12382-12393, 2007 | 387 | 2007 |
| HIV-1 DNA predicts disease progression and post-treatment virological control JP Williams, J Hurst, W Stöhr, N Robinson, H Brown, M Fisher, S Kinloch, ... elife 3, e03821, 2014 | 320 | 2014 |
| Human immunodeficiency virus type 1-specific CD8+ T-cell responses during primary infection are major determinants of the viral set point and loss of CD4+ T cells H Streeck, JS Jolin, Y Qi, B Yassine-Diab, RC Johnson, DS Kwon, ... Journal of virology 83 (15), 7641-7648, 2009 | 270 | 2009 |
| Antiretroviral therapy with the integrase inhibitor raltegravir alters decay kinetics of HIV, significantly reducing the second phase JM Murray, S Emery, AD Kelleher, M Law, J Chen, DJ Hazuda, ... Aids 21 (17), 2315-2321, 2007 | 239 | 2007 |
| Identification of circulating antigen-specific CD4+ T lymphocytes with a CCR5+, cytotoxic phenotype in an HIV-1 long-term nonprogressor and in CMV infection JJ Zaunders, WB Dyer, B Wang, ML Munier, M Miranda-Saksena, ... Blood 103 (6), 2238-2247, 2004 | 211 | 2004 |
| In vivo, nucleoside reverse-transcriptase inhibitors alter expression of both mitochondrial and lipid metabolism genes in the absence of depletion of mitochondrial DNA PWG Mallon, P Unemori, R Sedwell, A Morey, M Rafferty, K William, ... Journal of Infectious Diseases 191 (10), 1686-1696, 2005 | 210 | 2005 |
| Cytotoxic CD4 T cells—Friend or foe during viral infection? JA Juno, D Van Bockel, SJ Kent, AD Kelleher, JJ Zaunders, CML Munier Frontiers in immunology 8, 19, 2017 | 205 | 2017 |
| Marked epitope-and allele-specific differences in rates of mutation in human immunodeficiency type 1 (HIV-1) Gag, Pol, and Nef cytotoxic T-lymphocyte epitopes in acute/early … ZL Brumme, CJ Brumme, J Carlson, H Streeck, M John, Q Eichbaum, ... Journal of virology 82 (18), 9216-9227, 2008 | 203 | 2008 |
| HIV disease progression despite suppression of viral replication is associated with exhaustion of lymphopoiesis D Sauce, M Larsen, S Fastenackels, M Pauchard, H Ait-Mohand, ... Blood, The Journal of the American Society of Hematology 117 (19), 5142-5151, 2011 | 199 | 2011 |
| Oligoclonal Expansions of CD8+ T Cells in Chronic HIV Infection Are Antigen Specific JDK Wilson, GS Ogg, RL Allen, PJR Goulder, A Kelleher, AK Sewell, ... The Journal of experimental medicine 188 (4), 785-790, 1998 | 199 | 1998 |
| T follicular helper cells have distinct modes of migration and molecular signatures in naive and memory immune responses D Suan, A Nguyen, I Moran, K Bourne, JR Hermes, M Arshi, HR Hampton, ... Immunity 42 (4), 704-718, 2015 | 197 | 2015 |
